Lee Duna to Science@beehaw.orgEnglish · 1 year agoFirst trial of ‘base editing’ in humans lowers cholesterol — but raises safety concernswww.nature.comexternal-linkmessage-square2fedilinkarrow-up141arrow-down10cross-posted to: [email protected]
arrow-up141arrow-down1external-linkFirst trial of ‘base editing’ in humans lowers cholesterol — but raises safety concernswww.nature.comLee Duna to Science@beehaw.orgEnglish · 1 year agomessage-square2fedilinkcross-posted to: [email protected]
minus-squareappel@whiskers.bim.boatslinkfedilinkarrow-up1·1 year agoCool picture. From what I gather they did not use a viral vector here? It mentions nanoparticles. I also wonder if there were any adverse affects among the animal tests too.
Cool picture. From what I gather they did not use a viral vector here? It mentions nanoparticles. I also wonder if there were any adverse affects among the animal tests too.
Yeah looks like lipid nanoparticles.